Abstract
Serious, and occasionally fatal, anaphylactic-like (anaphylactoid) reactions may occur when a patient is exposed to a drug for the first time1. Apart from the penicillins2, nothing is known of the nature of antigenic or sensitizing drug determinants and, as yet, there is no evidence for the involvement of IgE antibodies in most drug reactions1,3. Muscle relaxants such as alcuronium have been implicated in many life-threatening anaphylactoid reactions4,5 but the mechanisms remain unclear6. We have now investigated the possibility that drug-specific IgE antibodies are involved by using an alcuronium–carrier complex in a radioim-munoassay with patients' sera. Alcuronium-reactive antibodies were found in five drug-sensitive subjects and most of the antibodies cross-reacted with other muscle relaxants and with a variety of apparently structurally unrelated drugs. Structure–activity studies designed to explore the molecular basis of the antibody binding established that quaternary and tertiary ammonium ions were the complementary allergenic sites on the reactive drugs. These structures occur widely in many drugs but also in foods, cosmetics, disinfectants and industrial materials. Hence, there would seem to be ample opportunity for sensitive individuals to come into contact with and synthesize IgE antibodies to these unusual, and previously unsuspected, antigenic determinants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Patterson, R. & Anderson, J. J. Am. med. Ass. 248, 2637–2645 (1982).
Ahlstedt, S. & Kristofferson, A. Prog. Allergy 30, 67–134 (1982).
Ackroyd, J. F. in Clinical Aspects of Immunology 3rd edn (eds Gell, P. G. H., Coombs, R. R. A. & Lachmann, P. J.) 913–961 (Blackwell, Oxford, 1975).
Lim, M. & Churchill-Davidson, H. C. Monogr. Anaesthes. 8, 65–136 (1981).
Fisher, M. M. & More, D. Anaesth. intensive Care 9, 226–234 (1981).
Fisher, M. M. & Munro, I. Anaesth. Analg. 62, 559–564 (1983).
Levy, M., Lipshitz, M. & Eliakim, M. Am. J. med. Sci. 177, 49–56 (1979).
Beaven, M. A. Anesthesiology 55, 3–5 (1981).
Adkinson, N. F. & Lichtenstein, L. M. Alfred Benzon Symp. 10, 123–140 (1977).
Fisher, M. M. Anesthesiology 52, 318–320 (1980).
Fisher, M. M. Anaesth. intensive Care 9, 235–241 (1981).
Mongar, J. F. & Whelan, R. F. J. Physiol., Lond. 120, 146–150 (1953).
Baldo, B. A., Wells, I. D. & Pepys, J. Clin. Allergy 4, 195–210 (1974).
Sundberg, L. & Porath, J. J. Chromatogr. 90, 87–98 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baldo, B., Fisher, M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306, 262–264 (1983). https://doi.org/10.1038/306262a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/306262a0
This article is cited by
-
Allergic and other adverse reactions to drugs used in anesthesia and surgery
Anesthesiology and Perioperative Science (2023)
-
Anaphylactic Responses to Neuromuscular Blockade Drugs and Reversal Drugs
Current Anesthesiology Reports (2023)
-
Perioperative Anaphylaxis: Evaluation and Management
Clinical Reviews in Allergy & Immunology (2022)
-
Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
JA Clinical Reports (2020)
-
Use of the relative release index for histamine in LAD2 cells to evaluate the potential anaphylactoid effects of drugs
Scientific Reports (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.